Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2005
10/26/2005EP1589031A2 Production of polyketides and other natural products
10/26/2005EP1589030A1 Bob-1 specific T cells and methods to use
10/26/2005EP1588761A2 Combinatorial strategies for polymer synthesis
10/26/2005EP1588713A1 Production of human papillomavirus HBV-11 capsid protein L1 and virus-like particles
10/26/2005EP1588712A1 Modulators of regulatory proteins
10/26/2005EP1588172A2 Method for identifying bhs-specific proteins and fragments thereof
10/26/2005EP1588167A2 Sperm specific lysozyme-like proteins
10/26/2005EP1588140A2 Cancer-associated nucleic acids and polypeptides
10/26/2005EP1588139A2 Rhesus monkey, dog and ferret melanin-concentrating hormone type 2 receptor
10/26/2005EP1587944A1 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
10/26/2005EP1587928A2 Human saa3 nucleic acid molecule, protein, and methods of use for same
10/26/2005EP1587927A2 Regulator/promoter for tunable gene expression and metabolite sensing
10/26/2005EP1587916A2 Cell cycle progression proteins
10/26/2005EP1587904A2 Glycosylation modified il-20
10/26/2005EP1587843A2 Combinatorial libraries of monomer domains
10/26/2005EP1587840A2 Method to form a protein microarray system
10/26/2005EP1587837A2 Prostate cancer diagnosis and treatment
10/26/2005EP1587834A2 Uses of mammalian cytokine; related reagents
10/26/2005EP1587832A1 Factor viii polypeptide
10/26/2005EP1587831A2 Spliced variants of lgr6
10/26/2005EP1587830A1 Peptide inhibitors of toxins derived from ll-37
10/26/2005EP1587829A1 Human protooncogene and protein encoded therein
10/26/2005EP1587828A1 Defensin protins
10/26/2005EP1587827A1 Obesity-related genes
10/26/2005EP1587826A2 Cross-protective epitopes of moraxella catarrhalis and use thereof
10/26/2005EP1587825A2 Antigen imitating extracellular areas of membrane proteins of type iii produced from intracellular pathogenic micro-organisms, derived conformational antibodies and the use thereof
10/26/2005EP1587822A2 Peroxisome proliferator-activated receptor
10/26/2005EP1587816A2 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection
10/26/2005EP1587544A1 p53 TREATMENT OF PAPILLOMARIVUS AND CARCINOGEN-TRANSFORMED CELLS IN HYPERPLASTIC LESIONS
10/26/2005EP1587541A2 Compositions and methods of tolerizing a primate to an antigen
10/26/2005EP1587537A2 Injectable vaccines against multiple meningococcal serogroups
10/26/2005EP1587532A2 Survivin-derived peptides and use thereof
10/26/2005EP1587530A2 The use of yop proteins or rho gtpase inhibitors as caspase-1 inhibitors
10/26/2005EP1587526A2 Mntf peptides and compositions and methods of use
10/26/2005EP1587481A2 Sensitive proteasome sensor constructs and methods for their design and use
10/26/2005EP1587476A2 Novel compositions and methods in cancer
10/26/2005EP1587405A2 Novel compositions and methods for cancer
10/26/2005EP1587404A2 Pigment epithelium derived factor from human plasma and methods of use thereof
10/26/2005EP1509540A4 Claudin polypeptides, polynucleotides, and methods of making and use thereof
10/26/2005EP1458847A4 Novel nucleic acids, polypeptides, methods of making, and uses thereof
10/26/2005EP1444264A4 Methods and materials for targeting and affecting selected cells
10/26/2005EP1410019B1 Cardiovascular safety assay
10/26/2005EP1354058B1 Isolation and characterisation of an anther-specific promoter (cofs) in cotton
10/26/2005EP1268851B1 Method of concentrating and recovering a viral enzyme activity from biological samples
10/26/2005EP1246837B1 Oligomers of nonpeptide restricted mimetics of dipeptides or tripeptides and the use thereof in the synthesis of synthetic proteins and polypeptides
10/26/2005EP1161527B1 Improved expression vector for consistent cellular expression of the tet on repressor in multiple cell types
10/26/2005EP1140148B1 Shelf-stable solution formulation of glucagon-like peptide-1
10/26/2005EP0973889B1 HUMAN CALCIUM CHANNELS ALFA1i SUBUNITS AND RELATED PROBES, CELL LINES AND METHODS
10/26/2005EP0963437B1 The process for the expression and production of the recombinant human beta-cis interferon
10/26/2005EP0916681B1 Neuropeptides originating in scorpion
10/26/2005EP0909273B1 Alpha-amylase transcription factor
10/26/2005EP0687301B1 Prohormone convertase transformed cells and polypeptide synthesis
10/26/2005EP0654075B1 New bacillus thuringiensis strains and their insecticidal proteins
10/26/2005EP0625048B2 Synthesis of human procollagens and collagens in recombinant dna systems
10/26/2005EP0506757B2 A recombinant human factor viii derivative
10/26/2005CN1688702A Use of recombinant measles viruses expressing epitopes of antigens of RNA viruses in the preparation of vaccine compositions
10/26/2005CN1688699A Method for the selection of recombinant clones comprising a sequence encoding an antidote protein to a toxic molecule
10/26/2005CN1688696A GHRH analogues
10/26/2005CN1688607A Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use
10/26/2005CN1688605A Novel immunogenic lipopeptides comprising T-helper and cytotoxic T lymphocyte (CTL) epitopes
10/26/2005CN1688604A Recombinant anti-osteopontin antibody and use thereof
10/26/2005CN1688602A Novel MHC II associated peptides
10/26/2005CN1688601A Nuclear factor of activated T cells receptor
10/26/2005CN1688364A Use of murine genomic regions identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer
10/26/2005CN1688340A Methods and compositions for modulating T helper (TH) cell development and function
10/26/2005CN1688335A Continuous cell line for the production of vaccines
10/26/2005CN1688323A Lentiviral vector-mediated gene transfer and uses thereof
10/26/2005CN1687132A Collagen and method for preparing collagen from skins of birds
10/26/2005CN1687131A Truncation type zona pellucida protein of pig ova and its expression method
10/26/2005CN1687130A Nucleus factor-kB p50 subunit antagonist peptide, preparation and application thereof
10/26/2005CN1687129A Nucleus factor-kB p65 subunit combination peptide, preparation and application thereof
10/26/2005CN1687128A Nucleus factor-kB p50 subunit combination peptide, preparation and application thereof
10/26/2005CN1687127A Stimulative phagocytizing factor and coded gene and application
10/26/2005CN1687126A Buthotoxin polypeptide and preparation method thereof
10/26/2005CN1687125A Method for constructing, expressing and purifying human recombination factor and application
10/26/2005CN1687124A Drought resistant correlative protein and coded gene of plant and application
10/26/2005CN1687123A Membrane process for extracting soybean protein peptide and technique of deep processing byproduct
10/26/2005CN1687122A Purple laver protein and polysaccharide product, and method of ultrasonic assistant extraction
10/26/2005CN1687121A Conjugated protein of recombined allergen actine and preparation method thereof
10/26/2005CN1687120A Protein for promoting plant growth and enhancing disease resistance of plant, and synthetic gene
10/26/2005CN1687119A Interfusion protein of antineoplastic genetic engineering composed of target short peptide of receptor of epidermal growth factor and Lidamycin
10/26/2005CN1687110A Method for separating lacti-streptocin from fermentation liquid of lacti-galactococcus
10/26/2005CN1687107A Method for separating purified immuno regulation active polypeptide from placenta of cattle
10/26/2005CN1224712C Vector
10/26/2005CN1224708C i (Neisseria meningitidis) antigens
10/26/2005CN1224707C Intracellular isoform of the interleukin-1 receptor antagonist
10/26/2005CN1224706C Methods for transforming plants to express bacillus thuringiensis delta-endotoxins
10/26/2005CN1224705C Toxoplasmosis composite multi-position genes
10/26/2005CN1224631C 11 segment human digestive tract tumoure blood vessel speicfic conjugated cyclopeptide GX series
10/26/2005CN1224627C Modified factor VIII
10/26/2005CN1224422C Vaccines comprising interleukin-12 and herpes simplex viral antigen
10/26/2005CN1224419C Orally administered peptides to ameliorate a therosclerosis
10/26/2005CN1224327C Production process of calcium caseinate
10/25/2005US6958433 Transgenic mice overexpressing aspartyl protease 2 (ASP2)
10/25/2005US6958388 Amino acid sequence for treating lung diseases, such as idiopathic pulmonary fibrosis
10/25/2005US6958387 Human serpin polypeptides
10/25/2005US6958386 MUM-1 protein expressed by multiple myeloma-related gene
10/25/2005US6958385 Bioactive peptides, uses thereof and process for the production of same
10/25/2005US6958361 Drugs, vaccines
10/25/2005US6958323 Nervous system disorders; cardiovascular disorders; gastrointestinal disorders
1 ... 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 ... 2916